BBCC 2026

Don S. Dizon MD, FACP, FASCO is Jane F. Desforges Chair in Hematology and Oncology at Tufts University. He is the Director of the Pelvic Malignancies Program at Lifespan Cancer Institute, Head of Community Outreach and Engagement at Legorreta Cancer Center, and Director of Medical Oncology at Rhode Island Hospital. Nationally he is the Vice Chair for Diversity, Equity, Inclusion, and Professional Integrity at SWOG Cancer Research Network. He also is a founding member of the Collaboration for Outcomes using Social Media in Oncology. His research foci include novel treatment of ovarian, uterine, and cervical cancers; communication; survivorship after cancer especially in sexuality; professional social media use; and advocacy on behalf of the sexual and gender minoritized (SGM) communities. He is a fellow of the American College of Physicians (FACP) and the American Society of Clinical Oncology (FASCO).

Dr. Ismail Jatoi is Professor in the Division of Surgical Oncology and Endocrine Surgery and holder of the Dale H. Dorn Endowed Chair in Surgery at the University of Texas Health Sciences Center in San Antonio, Texas. He obtained his undergraduate bachelor’s degree from Washington University in St. Louis and his MD and PhD degrees from St. Louis University. He is a Diplomate of the American Board of Surgery and a Fellow of the American College of Surgeons. He completed fellowship training in surgical oncology at the Royal Marsden Hospital in London, England. In recent years, his primary clinical focus has been on the diagnosis and treatment of breast cancer, and his research focuses on issues pertaining to cancer screening and epidemiology, and the management of breast cancer. Dr. Jatoi has published approximately 170 papers, edited, or authored 8 books, and written 8 book chapters. He has published in numerous high-impact journals, including the New England Journal of Medicine, JAMA, Lancet, British Medical Journal, Journal of Clinical Oncology, Lancet Oncology, JAMA Oncology, and the Journal of the National Cancer Institute. Dr. Jatoi has had longstanding interest in implementation science, the design and analysis of cancer clinical trials, and the development of evidence-based clinical practice guidelines. He has previously served as Co-Director of the San Antonio Breast Cancer Symposium (SABCS), the Breast Cancer Executive Committee of the Southwest Oncology Group (SWOG) and is the co-Principal Investigator of the NRG Oncology effort at the University of Texas Health Science Center in San Antonio and serves on the national NRG Oncology Breast Cancer Committee and Working Group.

Prof. Dr. Rajesh Balakrishnan completed MD Radiation Oncology from Christian Medical College Vellore in 2004 and is working at CMC Vellore since then. He was awarded DNB Radiation oncology in 2005. He also had Image Guided RT training at Clatter Bridge Centre of Oncology, Liverpool, United Kingdom and Breast / Genitourinary Radiotherapy training at Peter MacCallum Centre Australia. His current position is Professor, Department of Radiation Oncology, Christian Medical College, Vellore.
He is specialized in treating malignancies with Radiotherapy including Brachytherapy, Chemotherapy, Targeted Therapies and Immunotherapy. He has been part of more than 30 clinical trials (national and international). His main areas of interest include Breast cancer, Brain tumors, Lymphomas, Pediatric tumors, GI/GU Oncology. His special areas of interest include Reirradiation and Radiosurgery. He is a member of various organizations like AROI, ISNO, ISMPO, ESTRO, ESMO, IBS, SIOP, TISS, IBS, ISCR, AMPI etc.
He has been an invited faculty in conferences both nationally and internationally. He has more than 20 publications in peer reviewed journals and is a reviewer in more than 10 journals. He has been guide for many postgraduate students in his institution.

Dr. Debnarayan Dutta is the Senior Consultant & Head of the Department of Radiation Oncology at Amrita Institute of Medical Sciences, Kochi, India. He is a reputed radiation oncologist, worked in Apollo Cancer Hospital Chennai as a senior consultant before joining Amrita. He did his MBBS from National Medical College, Kolkata in the year 1999 and did MD in radiation oncology from the Nilratan Sirkar Medical College, Kolkata from 2003 to 2006. After completing his MD training, he joined Tata Memorial Hospital, Mumbai as neuro-oncologist & stereotactic radiosurgery fellow in 2006. Then he did fellowship in IMRT in head & neck radiation oncology from Tata Memorial Hospital, Mumbai. He was trained at Tata Memorial Hospital after post-graduation for almost 4 years, from 2006 till 2010. He joined Apollo Cancer Hospital Chennai in 2010 as consultant and was an integral part of CyberKnife treatment team. He was awarded the prestigious ‘MERIT’ award for being a promising cancer researcher by the American Society of Clinical Oncology (ASCO) in 2008, presenter in ‘Hosino’ young investigator award at Yokohama Japan 2009, awarded ‘Neucletron Fellowship’ in 2010. He received aboard training from Antoine Lacassagne Cancer Centre, Nice and Oscar Lambret Cancer Centre, Lille, France for CyberKnife. He had a short stint at Munich CyberKnife Centre, Munich. He is one of the first few Cyberknife users in India and regarded as an expert in radiosurgery & SBRT. He received training from Varian SBRT training center at Lisbon, Portugal in 2013 and was part of IBA proton users meeting at Paris in 2014. He is an eminent speaker in radiosurgery and neuro-oncology, with more than 100 national and international presentations in different academic forums. He has 40 indexed publications, 50 indexed abstracts, chapters in three books and is reviewer of few indexed journals. He is persuading his academic interest as PhD student in Vellore Institute of Technology (VIT). His thesis is on molecular prognostication of head & neck cancer.

Professor Ian Kunkler is Consultant in Clinical Oncology at the Edinburgh Cancer Centre, University of Edinburgh. He qualified in Medicine at Cambridge University and undertook clinical training at St Bartholomew’s Hospital in London. After training in general medicine in Nottingham, he moved to Edinburgh and trained in Clinical Oncology under Professor Bill Duncan. He spent a year as a French Government and EEC research fellow in the Department of Curietherapy with Professor Daniel Chassagne and Dr Alain Gerbaulet. He was appointed Consultant in Clinical Oncology in Sheffield, specialising in the treatment of brain tumours, breast cancer and lymphomas. He returned to Edinburgh in 1992 where he is senior specialist in Clinical Oncology for breast cancer.

His research interests are in adjuvant trials of radiotherapy for breast cancer, the development of biosensors in cancer management and the application of telemedicine in cancer care. He is Chief Investigator of the BIG 2-04 MRC/EORTC SUPREMO trial, the PRIME 2 trial and Principal Investigator at Edinburgh University in the European FP7 large scale integrating project (METOXIA) on translating the hypoxic microenvironment. He has edited two editions of Walter and Miller’s Textbook of Radiotherapy and published over 100 articles. He is a past President of the British Oncological Association

Prof. Dr. Dodul Mondal is a Radiation Oncologist and a director at Max Super Speciality Hospital, Saket, New Delhi, India. He covers cancer treatments, such as Radiation, Chemotherapy, Immunotherapy, and Targeted therapy. He is experienced Radiation and Clinical Oncologist with a demonstrated history of working in the hospital & health care industry. He is skilled in Proton Beam Therapy, SRS, SBRT, IMRT, IGRT and Brachytherapy for various malignancies. He is currently working with Indraprastha Apollo Hospitals, Delhi which is first JCI accredited hospital in India. He provides consultancy in setting up new oncology facility including radiation facility also provides analytical information in oncology related market driven services. He has worked as a faculty in Radiation Oncology Department at AIIMS Delhi, NCI.

Dr. Md. Zaker Ullah is a Consultant Oncoplastic Breast & General Surgeon at The Harley Street Clinic, The Holly Private Hospital and Barts Health NHS Trust.
Dr Ullah has a vast range of experience in breast cancer and general surgery. Dr Ullah has trained in a number of world-renowned hospitals including The Royal Marsden, St Mary’s and Royal Free. Dr Ullah has a keen interest in Oncoplastic Breast Surgery and he has been trained in hospitals such as The Royal Marsden Hospital, St Mary’s Hospital & The Royal Free Hospital.
This training has enabled him to gain extensive experience in both benign and malignant breast conditions, as well as inspiring him to introduce the one-stop breast clinic at Whipps Cross Hospital.